19th Global Hepatitis Summit (GHS 2025)

Join us at The Westin Bonaventure Hotel & Suites, Los Angeles, USA March 18 – 21, 2025 for the 19th Global Hepatitis Summit (GHS 2025), a 50-year legacy of the International Symposium on Viral Hepatitis and Liver Disease (ISVHLD).

The GHS 2025 faculty has been carefully selected to achieve the global diversity and gender balance that is reflective of our scientific community today. GHS 2025 will feature the latest developments in viral hepatitis, along three distinct tracks basic/translational, clinical, and public health. 2025 has been designated by the WHO as a milestone year to assess progress towards the 2030 goals to eliminate Hepatitis C and Hepatitis B. Accordingly, GHS 2025 will be taking stock of progress to date while looking ahead towards research, clinical care, and public health interventions needed to achieve global goals to eliminate hepatitis.

GHS 2025 will be as much a networking event as a cutting-edge research conference, featuring dedicated tracks for health practitioners and inspiring workshops for those working in the liver and hepatitis space, where renown speakers will highlight the most exciting recent results in the field and provide perspectives for research and patient management.

3-TIER APPROACH

Basic-Translational Science

• HCV/flavivirus virology
• HCV/flavivirus immunology
• HBV/HDV virology
• HBV/HDV immunology
• Preclinical therapeutics HBV/HDV
• Hepatocellular carcinoma
• Other viruses (including HEV)
• Liver inflammation and fibrogenesis
• Liver pathogen detection and discovery

Clinical Science

• HCV screening, clinical care delivery and outcomes
• HBV screening, clinical care delivery and outcomes
• Approved HBV treatments
• New and promising HBV therapies (Phase 2 and beyond) and diagnostics
• Approved and promising new HDV therapies and diagnostics
• Viral hepatitis coinfections and morbidities: HIV, MASLD/MASH
• Hepatocellular carcinoma clinical
• Hepatocellular carcinoma treatment
• Biomarkers for liver diseases
• Other viruses, clinical and treatment

Public Health

• Prevention of new infections, including vaccination and injection safety
• Epidemiology of HCV
• Epidemiology of HBV/HDV
• Epidemiology of hepatocellular carcinoma
• HBV elimination: achievements and challenges
• HCV elimination: achievements and challenges
• Simplified community and clinic- based approaches to viral hepatitis care cascade
• Strategies for equitable service delivery to overcome disparities in viral hepatitis